Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New treatments for acute stroke.

× No keyword cloud information.

7 in total

1. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage.

Authors: Shin Jung; Kyung-Sub Moon; Tae-Young Jung; In-Young Kim; Young-Hwa Lee; Hyang-Hwa Rhu; Heung-Suk Sun; Young-Il Jeong; Kyung-Keun Kim; Sam-Suk Kang
Journal: J Neurooncol Date: 2006-02 Impact factor: 4.130

2. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189.

Authors: S Y Cheng; M Nagane; H S Huang; W K Cavenee
Journal: Proc Natl Acad Sci U S A Date: 1997-10-28 Impact factor: 11.205

Review 3. The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors: Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal: Mol Neurobiol Date: 2013-10-10 Impact factor: 5.590

4. Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator.

Authors: Haitao Jiang; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal: Anal Chem Date: 2010-07-15 Impact factor: 6.986

New treatments for acute stroke.

1. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage.

2. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189.

Review 3. The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

4. Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator.

5. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

6. Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor.

7. Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.